[A Case of Radical Resection after Neoadjuvant Chemotherapy for Rectal Cancer with Pelvic Abscess]

Gan To Kagaku Ryoho. 2023 Dec;50(13):1615-1617.
[Article in Japanese]

Abstract

A 66-year-old man with a history of frequent diarrhea was diagnosed with rectal cancer with obstruction and a pelvic abscess. Following a transverse colostomy, he was referred to our hospital. The initial diagnosis was rectal cancer(cT4a N1bM0, cStage Ⅲb)and a pelvic abscess due to tumor perforation. To address this condition, we performed neoadjuvant chemotherapy using a combination of 5-fluorouracil, Leucovorin, oxaliplatin, and irinotecan(FOLFOXIRI). Following 6 courses of FOLFOXIRI, the abscess disappeared and no signs of tumor progression and distant metastases were detected. Subsequently, we performed radical resection with D3LD2 lymph node dissection, leading to a pathological diagnosis of ypT3N1aM0, ypStage Ⅲb. The patient then underwent adjuvant chemotherapy with capecitabine and oxaliplatin(CAPOX). No recurrence was observed after 9 months of follow-up.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Abdominal Abscess*
  • Abscess / drug therapy
  • Abscess / etiology
  • Abscess / surgery
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Fluorouracil / therapeutic use
  • Humans
  • Leucovorin / therapeutic use
  • Male
  • Neoadjuvant Therapy
  • Oxaliplatin / therapeutic use
  • Rectal Neoplasms* / complications
  • Rectal Neoplasms* / drug therapy
  • Rectal Neoplasms* / surgery

Substances

  • Oxaliplatin
  • Fluorouracil
  • Leucovorin